Keyword: Pharma

News

Bayer to Invest More Than €500 Million in Haemophilia Pipeline

12.03.2014 - BayerHealthcare plans to invest more than €500 million at its sites in Wuppertal and Leverkusen, Germany, to expand capacity for production of its recombinant factor VIII...

News

WeylChem U.S. Inc. expanding at Kershaw County facility

11.03.2014 - WeylChem U.S. Inc., a provider of custom manufacturing and tolling services, as well as advanced intermediates and reagents is announcing the expansion of its Kershaw County...

News

Gene Mutations for Type 2 Diabetes Discovered

04.03.2014 - Scientists have uncovered gene mutations that slash the risk of Type 2 diabetes regardless of age and weight, offering drugmakers a novel target to combat one of the major health...

Sites & Services

ASEAN Harmonization

12.02.2014 - Economic Growth - The Association of Southeast Asian Nations (ASEAN) - comprised of Malaysia, Burma, the Philippines, Singapore, Thailand, Vietnam, Brunei, Cambodia, Indonesia...

Chemistry & Life Sciences

PCRAMS is a Booming Business

16.01.2014 - Global Growth - Milan-based Chemical Pharmaceutical Association (CPA) recently published the report "The World Pharmaceutical Contract Research and Manufacturing Services Industry...

Chemistry & Life Sciences

Helsinn Reaps Benefits of Cytotoxic Molecule Demand

16.01.2014 - Strong Start - After beginning its investment in a brand-new cytotoxic molecule facility in Biasca, Switzerland, in 2011, Helsinn started production in July 2012. Now one and a...

News

Nick Hyde joined Results Healthcare as Managing Director

03.01.2014 - Results Healthcare, a healthcare corporate finance and strategy specialist announced the appointment of life sciences industry veteran Nick Hyde as Managing Director. Hyde joined...

Plant Construction & Process Technology

Double Risk with an Upgrade

31.10.2013 - Trial And Error - Despite a 150-year history and an aggregate R&D expenditure of $150 billion per year, innovation in the modern pharmaceutical industry is essentially still based...